Febuxostat
DrugBank ID: DB04854
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| obsolete hyperuricemia (disease) | 1.0000 | KG+DL |
| hypouricemia, renal | 0.9999 | DL |
| hypoxanthine guanine phosphoribosyltransferase partial deficiency | 0.9998 | DL |
| Lesch-Nyhan syndrome | 0.9968 | DL |
| early-onset familial noncirrhotic portal hypertension | 0.9189 | DL |
| hepatoportal sclerosis | 0.9189 | DL |
| hepatopulmonary syndrome | 0.9189 | DL |
| idiopathic copper-associated cirrhosis | 0.9189 | DL |
| primitive portal vein thrombosis | 0.9189 | DL |
| hepatic porphyria | 0.9121 | DL |
| disorder of phenylalanine metabolism | 0.7904 | DL |
| disorder of tyrosine metabolism | 0.7722 | DL |
| teratogenic Pierre Robin syndrome | 0.7716 | DL |
| cholelithiasis | 0.7048 | DL |
| Tay-Sachs disease, b variant | 0.6526 | DL |
| tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | 0.6400 | DL |
| Wiskott-Aldrich syndrome 2 | 0.6335 | DL |
| Tay-Sachs disease, B1 variant | 0.6294 | DL |
| anuria | 0.6159 | DL |
| alacrima, achalasia, and intellectual disability syndrome | 0.6084 | DL |
| glycogen storage disease due to hepatic glycogen synthase deficiency | 0.5994 | DL |
| genetic otorhinolaryngological malformation | 0.5993 | DL |
| Ramon syndrome | 0.5978 | DL |
| homozygous familial hypercholesterolemia | 0.5957 | DL |
| obsolete hypertension, diastolic, resistance to | 0.5938 | DL |
| hypermobility syndrome | 0.5859 | DL |
| obsolete left bundle branch block | 0.5838 | DL |
| transient infantile hypertriglyceridemia and hepatosteatosis | 0.5825 | DL |
| neonatal epileptic encephalopathy due to glutaminase deficiency | 0.5786 | DL |
| obsolete pathologic fracture | 0.5782 | DL |
| myopathy due to calsequestrin and SERCA1 protein overload | 0.5768 | DL |
| methylcobalamin deficiency type cblDv1 | 0.5716 | DL |
| idiopathic bilateral vestibulopathy | 0.5647 | DL |
| semicircular canal dehiscence syndrome | 0.5647 | DL |
| childhood encephalopathy due to thiamine pyrophosphokinase deficiency | 0.5637 | DL |
| ocular tuberculosis | 0.5635 | DL |
| erythrocyte AMP deaminase deficiency | 0.5629 | DL |
| toxic labyrinthitis | 0.5629 | DL |
| guttate psoriasis | 0.5627 | DL |
| isolated tracheo-esophageal fistula | 0.5619 | DL |
| susceptibility to mononeuropathy of the median nerve, mild | 0.5593 | DL |
| sunburn | 0.5587 | DL |
| muscular disease | 0.5568 | DL |
| polydipsia | 0.5563 | DL |
| myopathy, proximal, and ophthalmoplegia | 0.5549 | DL |
| phosphohydroxylysinuria | 0.5520 | DL |
| cystic hygroma | 0.5517 | DL |
| maternal riboflavin deficiency | 0.5496 | DL |
| glomerulocystic kidney disease with hyperuricemia and isosthenuria | 0.5452 | DL |
| silent sinus syndrome | 0.5446 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.